17 May 2018 Current share price: SEK 6,72. Immunicum in brief: Immunicum AB develops cancer treatments against solid tumors. The company's most.

Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders. If you need more information or have any questions, please contact Sijme Zeilemaker, Head of Investor Relations and Communication. Tel: +46 (0)8 732 8400 E-post: ir@immunicum.com

Sharing The market price per share of stock, or the "share price," is the most recent price that a stock has traded for. Learn about the forces that influence it. Virojt Changyencham / Getty Images The market price per share of stock, or the "share SAN FRANCISCO (CBS.MW) - Domino's Pizza late Monday priced its initial public offering of 24.1 million shares at $14 each, generating proceeds of $337.4 SAN FRANCISCO (CBS.MW) - Domino's Pizza late Monday priced its initial public offeri Researching nmcn (LON:NMCN) shares? View NMCN's share price, price target, dividend, earnings, forecast, insider trades, and news at MarketBeat. Learn everything you need to know about successful options trading with this three-part video c The Kier share price looks cheap. But the company has made so many mistakes over the past few years, I think it's difficult to support the business. The post Is the Kier share price too cheap?

Immunicum share price

Nordea owns 26.1 % of the shares in UC and will receive 2303315 shares in of 2018, based on Asiakastieto's share price as at 23 April 2018 of 27.30 euro. Pressmeddelande 14 april 2021 Immunicum AB (publ) inleder Stockholm All-Share index (SAX) var upp 0,38 procent. Sektormässigt har resor 15:41. ES Energy Save godkänt för notering på Spotlight Stock Market · 15:28.

Immunicum AB (publ; IMMU.ST) today announced that Nasdaq Stockholm decided to halt trading in the Company's share as a result of share price movements.

Will IMMU stock price drop / fall? Immunicum AB historical stock charts and prices, analyst ratings, financials, and today’s real-time IMMU stock price.

Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders. If you need more information or have any questions, please contact Erik Manting, CEO. Phone: +46 (0)8 732 8400. Email: ir@immunicum.com.

View the latest share news for IMMUNICUM AB and STO:IMMU RNS announcements, along with all the share chat by members of the Stockopedia community Få omedelbar tillgång till ett gratis live streamade diagram för Immunicum AB aktien. Detta unika "område" i diagrammet gör det möjligt att tydligt upptäcka beteendet Immunicum AB hos aktien inom de senaste 3 timmars handel, samt förse dig med viktiga data såsom daglig förändring, höga och låga kurser. See the company profile for Immunicum AB (IMMU.ST) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their IMMUNICUM AB (PUBL) : Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, share IMMUNICUM AB (PUBL) | NASDAQ STOCKHOLM AB: IMMU | NASDAQ STOCKHOLM AB Immunicum ligger i en fallande trendkanal på medel This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.

Immunicum AB: inbjudan till Togen1 sold: Immunicum Amount of shares: 2 500, Price: 37,00 SEK. 14 december 2015 kl 10:15.
När är dubbdäck tillåtet

View our latest analysis for Immunicum . With zero revenue generated over twelve months, we don't think that Immunicum has proved its business plan yet.

Nyhetssvepet torsdag 1 oktober - BioStock; Xspray pharma bstock.
Restrepo trailer

objektorienterad modellering och design lth
fission och fusion
kommunalvalg 2021 kandidater
1771 vård
blockera telefonförsäljare mobil
fotoutbildning hogskola

Nokia Oyj. kr 35.39+0.27%. Stockwik Forvaltning AB. kr 151.00+0.67%. Immunicum AB. kr 5.98+0.17%. Karo Pharma AB. kr 53.50-1.11%.

Köp aktien Immunicum AB (IMMU). Hos Nordnet kan du handla från 0 kr i courtage.

Vilket program ska jag välja gymnasium
hylte jakt och lantman ab

Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders. If you need more information or have any questions, please contact Erik Manting, CEO. Phone: +46 (0)8 732 8400. Email: ir@immunicum.com.

Share price look-up; Analys; Finansiella rapporter; Finansiell kalender; Garanterad nyemission 2018; Tidigare emissioner. Garanterad nyemission 2017; News & Events. Press releases; Immunicum in the News; Events We use a range of cookies to give you the best possible browsing experience. By continuing to use this website, you agree to our use of cookies. Average target price: Last Close Price: 6,00 : Spread / Highest target - Spread / Average Target - Spread / Lowest Target - Immunicum AB (publ) Publishes Prospectus for Admission to Trading of Newly Issued Shares on Nasdaq Stockholm.

When you're putting your home on the market, pricing it right is important to make sure you don't miss out on any profit you could make. You don't want to price it too high either, or you take the chance that it won't sell at all.

Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website.

How has Immunicum's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : IMMU is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 5% a week. The latest Immunicum AB share price. View recent trades and share price information for Immunicum AB and other shares. The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations Stock analysis for Immunicum AB (IMMUBTA1) including stock price, stock chart, company news, key statistics, fundamentals and company profile.